LivaNova Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Livanova (LIVN) PT Lowered to $65 at Piper Sandler
April 29, 2020 3:39 PM EDTPiper Sandler analyst Matt O'Brien lowered the price target on Livanova (NASDAQ: LIVN) to $65.00 (from $80.00) while maintaining an Overweight rating.
negative commentary and outlook but lots value trapped in the stock... MoreLivaNova plc (LIVN) Misses Q1 EPS by 10c, Revenues Miss; Updated FY20 EPS Guidance Below Consensus
April 29, 2020 6:21 AM EDTLivaNova plc (NASDAQ: LIVN) reported Q1 EPS of $0.33, $0.10 worse than the analyst estimate of $0.43. Revenue for the quarter came in at $242.4 million versus the consensus estimate of $244.1 million.
"As a healthcare company committed to improving the lives of patients around the world, LivaNova is closely monitoring the COVID-19 situation. Being true to our values, we prioritize patients and their well-being, and we are working tirelessly to... More
